Mineralys Therapeutics In... (MLYS)
undefined
undefined%
At close: undefined
11.90
0.59%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -71.90M -29.80M -19.41M -3.43M
Depreciation & Amortization - - - -
Stock-Based Compensation 5.06M 455.00K 80.00K 1K
Other Working Capital -7.47M 772.00K 4.08M 480.00K
Other Non-Cash Items -6.87M -649.00K 684.00K 482.00K
Deferred Income Tax - - - -
Change in Working Capital -7.47M 772.00K 4.08M 480.00K
Operating Cash Flow -81.17M -29.22M -14.56M -2.46M
Capital Expenditures - - - -
Acquisitions - - - -
Purchase of Investments -347.97M -71.76M - -
Sales Maturities Of Investments 187.50M 50.00M - -
Other Investing Acitivies - -21.76K - -
Investing Cash Flow -160.47M -21.76M - -
Debt Repayment - - - -
Common Stock Repurchased - -1.63M - -20.00K
Dividend Paid - - - -
Other Financial Acitivies 516.00K 129.65M 23.81M 3.83M
Financial Cash Flow 203.25M 128.02M 23.81M 3.83M
Net Cash Flow -38.40M 77.04M 9.25M 1.37M
Free Cash Flow -81.17M -29.22M -14.56M -2.46M